TG and neoplasm: In contrast to Tg and TgAb, serum CA19-9 levels may be used as a surrogate tumor marker for patients with PTC regardless of the amount of residual thyroid tissue i.e., after hemithyroidectomy as well asand after total thyroidectomy.